| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 146939-27-7 | Ziprasidone | C21H21ClN4OS |
| 146943-43-3 | (S)-Diethyl 2-(4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioate | C24H29N5O6 |
| 146944-27-6 | (4-Benzylmorpholin-2-yl)acetic acid | C13H17NO3 |
| 146950-68-7 | N4-Cyclopropyl-3,4-pyridinediamine | C8H11N3 |
| 146953-81-3 | N-[(1,1-Dimethylethoxy)carbonyl]-L-leucine-15N | C11H21NO4 |
| 146954-74-7 | 5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-2'-deoxy-2'-fluorouridine | C30H29FN2O7 |
| 146954-75-8 | 5'-O-(4,4-Dimethoxytrityl)-2'-deoxy-2'-fluorouridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | C39H46FN4O8P |
| 146954-76-9 | N-Benzoyl-2'-deoxy-2'-fluorocytidine | C16H16FN3O5 |
| 146955-45-5 | (Z)-7-Tetradecen-2-one | C14H26O |
| 146955-66-0 | Ken-React NZ 37 | C38H54N2O10Zr |
| 146958-06-7 | Formamidine hydrobromide | CH4N2.HBr |
| 146960-90-9 | 1,1'-Bis(dicyclohexylphosphino)ferrocene | C34H52FeP2 |
| 146982-24-3 | Fmoc-L-aspartic acid 4-allyl ester | C22H21NO6 |
| 146982-27-6 | N-Fmoc-N'-allyoxycarbonyl-L-lysine | C25H28N2O6 |
| 146983-96-2 | 1-Iodo-1H,1H,2H,2H-perfluorotetradecane | C14H4F25I |
| 146984-27-2 | 2H-1,2,3-Triazole-2-ethanol | C4H7N3O |
| 146984-79-4 | 3-Chloro-6-hydroxy-2-methoxybenzoic acid | C8H7ClO4 |
| 146986-50-7 | Y-27632 dihydrochloride | C14H23Cl2N3O |
| 146987-10-2 | N-Fmoc-N'-biotinyl-L-lysine | C31H38N4O6S |
| 146987-99-7 | NZ 39 | C21H30O9Zr |
| 146997-97-9 | 2,6-Pyridinediamine sulfate | 2(C5H7N3).H2SO4 |
| 146998-27-8 | N6-[4-[[4-(Dimethylamino)phenyl]azo]benzoyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine | C36H37N5O5 |
| 146998-31-4 | 4-[4-(Dimethylamino)phenylazo]benzoic acid N-succinimidyl ester | C19H18N4O4 |
| 147006-47-1 | 5-Bromo-4(1H)-quinazolinone | C8H5BrN2O |
| 147009-08-3 | 2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide | C14H17N3O |
| 147009-31-2 | 2,3,4,9-Tetrahydro-3-hydroxy-1H-carbazole-6-carbonitrile | C13H12N2O |
| 147009-33-4 | 6-Cyano-3-N-methylamino-1,2,3,4-tetrahydrocarbazole | C14H15N3 |
| 147011-41-4 | 1-[2-(Bromomethyl)-1,3-dioxolan-2-yl]-N-(phenylmethyl)cyclopropanecarboxamide | C15H18BrNO3 |
| 147022-95-5 | 3'-O-Demethylarctigenin | C20H22O6 |
| 147025-05-6 | Decyl 2-(acetylamino)-2-deoxy-beta-D-glucopyranoside | C18H35NO6 |
| 147025-06-7 | Dodecyl 2-(acetylamino)-2-deoxy-beta-D-glucopyranoside | C20H39NO6 |
| 147027-09-6 | (2R,5R)-5-(Acetyloxy)-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester | C16H26O5S |
| 147027-10-9 | (1R,2S,5R)-Menthyl-(2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]oxathiolane-2-carboxylic acid | C18H27N3O4S |
| 147030-01-1 | Quiflapon sodium | C34H34ClN2O3S.Na |
| 147030-48-6 | 2-[2,6-Diiodo-4-[(2-methyl-3-benzofuranyl)methyl]phenoxy]acetic acid | C18H14I2O4 |
| 147054-81-7 | 4-Phenylaminopent-3-en-2-one | C11H13NO |
| 147059-46-9 | Rocaglaol | C26H26O6 |
| 147059-75-4 | Trovafloxacin monomethanesulfonate | C20H15F3N4O3.CH4O3S |
| 147065-05-2 | 4-Chloro-D-phenylalanine | C9H10ClNO2 |
| 147065-06-3 | 4-Nitro-D-phenylalanine hydrochloride | C9H10N2O4.HCl |
| 147080-28-2 | 5-(Methylthio)indoline | C9H11NS |
| 147081-29-6 | (S)-4-N-Boc-2-methylpiperazine | C10H20N2O2 |
| 147081-44-5 | (S)-(-)-1-Boc-3-aminopyrrolidine | C9H18N2O2 |
| 147081-49-0 | (R)-(+)-1-Boc-3-aminopyrrolidine | C9H18N2O2 |
| 147081-59-2 | tert-Butyl (3S)-3-(methylamino)pyrrolidine-1-carboxylate | C10H20N2O2 |
| 147081-80-9 | tert-Butyl piperazin-1-ylcarbamate | C9H19N3O2 |
| 147081-85-4 | 4-(1H-Imidazol-1-yl)piperidine | C8H13N3 |
| 147082-78-8 | (1-Methyl-4-piperidinyl)[1-(2-phenylethyl)-1H-imidazol-2-yl]methanone | C18H23N3O |
| 147083-36-1 | 6,11-Dihydro-11-(1-methyl-4-piperidinylidene)-5H-imidazo[2,1-b][3]benzazepine | C18H21N3 |
| 147084-10-4 | Alcaftadine | C19H21N3O |